CD300c Antibody (03) [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06451UV
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Flow Cytometry
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 03
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CD300c Antibody (03) [DyLight 350]
Immunogen
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD300c (Accession#: NP_006669.1; Met1-Arg183).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for CD300c Antibody (03) [DyLight 350]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD300c
Long Name
CD300 Antigen-Like Family Member C
Alternate Names
CLM-6, CLM6, CMRF35, IGSF16
Gene Symbol
CD300C
Additional CD300c Products
Product Documents for CD300c Antibody (03) [DyLight 350]
Product Specific Notices for CD300c Antibody (03) [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...